{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:23:31Z","timestamp":1789190611059,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s12032-013-0808-0","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T13:47:05Z","timestamp":1386596825000},"source":"Crossref","is-referenced-by-count":20,"title":["HE4 combined with CA125: favorable screening tool for ovarian cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Nasrin","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Ghobadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Zahraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemn","family":"Mohammadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salahadin","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Bakhshi","family":"ganje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokoh","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"issue":"1","key":"808_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"s1","key":"808_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1525-1438.2001.11(suppl.1)sup1003.x","volume":"11","author":"U Menon","year":"2001","unstructured":"Menon U, Jacobs I. Ovarian cancer screening in the general population: current status. Int J Gynecol Cancer. 2001;11(s1):3\u20136.","journal-title":"Int J Gynecol Cancer"},{"issue":"10 suppl","key":"808_CR3","doi-asserted-by":"crossref","first-page":"200s","DOI":"10.1200\/JCO.2003.01.068","volume":"21","author":"RC Bast","year":"2003","unstructured":"Bast RC. Status of tumor markers in ovarian cancer screening. J Clin Oncol. 2003;21(10 suppl):200s\u20135s.","journal-title":"J Clin Oncol"},{"issue":"3","key":"808_CR4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2009.10.087","volume":"116","author":"MR Andersen","year":"2010","unstructured":"Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, et al. Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer. Gynecol Oncol. 2010;116(3):378\u201383.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"808_CR5","first-page":"15","volume":"4","author":"JA Rauh-Hain","year":"2011","unstructured":"Rauh-Hain JA, Krivak TC, del Carmen MG, Olawaiye AB. Ovarian cancer screening and early detection in the general population. Rev Obstet Gynecol. 2011;4(1):15.","journal-title":"Rev Obstet Gynecol"},{"issue":"1","key":"808_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0090-8258(88)90039-X","volume":"30","author":"VR Zurawski Jr","year":"1988","unstructured":"Zurawski VR Jr, Knapp RC, Einhorn N, Kenemans P, Mortel R, Ohmi K, et al. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma. Gynecol Oncol. 1988;30(1):7\u201314.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"808_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","volume":"10","author":"U Menon","year":"2009","unstructured":"Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327\u201340.","journal-title":"Lancet Oncol"},{"issue":"9","key":"808_CR8","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/cncr.22594","volume":"109","author":"JR Nagell van","year":"2007","unstructured":"van Nagell JR, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, McDonald JM, et al. Ovarian cancer screening with annual transvaginal sonography. Cancer. 2007;109(9):1887\u201396.","journal-title":"Cancer"},{"issue":"6","key":"808_CR9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","volume":"19","author":"MT Galgano","year":"2006","unstructured":"Galgano MT, Hampton GM, Frierson HF. Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol. 2006;19(6):847\u201353.","journal-title":"Mod Pathol"},{"issue":"4","key":"808_CR10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1258\/acb.2011.011258","volume":"49","author":"B Nagy","year":"2012","unstructured":"Nagy B, Krasznai ZT, Balla H, Csob\u00e1n M, Antal-Szalm\u00e1s P, Hern\u00e1di Z, et al. Elevated human epididymis protein 4 concentrations in chronic kidney disease. Ann Clin Biochem. 2012;49(4):377\u201380.","journal-title":"Ann Clin Biochem"},{"issue":"13","key":"808_CR11","first-page":"3695","volume":"63","author":"I Hellstr\u00f6m","year":"2003","unstructured":"Hellstr\u00f6m I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003;63(13):3695\u2013700.","journal-title":"Cancer Res"},{"issue":"1","key":"808_CR12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","volume":"112","author":"RG Moore","year":"2009","unstructured":"Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol. 2009;112(1):40\u20136.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"808_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-1596-8-11","volume":"8","author":"EO Hamed","year":"2013","unstructured":"Hamed EO, Ahmed H, Sedeek OB, Mohammed AM, Abd-Alla AA, Ghaffar HMA. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response. Diagn Pathol. 2013;8(1):11.","journal-title":"Diagn Pathol"},{"issue":"4","key":"808_CR14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3802\/jgo.2011.22.4.244","volume":"22","author":"K Partheen","year":"2011","unstructured":"Partheen K, Kristjansdottir B, Sundfeldt K. Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass. J Gynecol Oncol. 2011;22(4):244\u201352.","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"808_CR15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","volume":"104","author":"T Gorp Van","year":"2011","unstructured":"Van Gorp T, Cadron I, Despierre E, Daemen A, Leunen K, Amant F, et al. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm. Br J Cancer. 2011;104(5):863\u201370.","journal-title":"Br J Cancer"},{"issue":"1","key":"808_CR16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1757-2215-6-44","volume":"6","author":"E Anastasi","year":"2013","unstructured":"Anastasi E, Granato T, Falzarano R, Storelli P, Ticino A, Frati L, et al. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer. J Ovarian Res. 2013;6(1):44.","journal-title":"J Ovarian Res"},{"issue":"10","key":"808_CR17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.clinbiochem.2011.04.011","volume":"44","author":"Y Park","year":"2011","unstructured":"Park Y, Lee J-H, Hong DJ, Lee EY, Kim H-S. Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases. Clin Biochem. 2011;44(10):884\u20138.","journal-title":"Clin Biochem"},{"issue":"1","key":"808_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","volume":"7","author":"L Bingle","year":"2006","unstructured":"Bingle L, Cross SS, High AS, Wallace WA, Rassl D, Yuan G, et al. WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res. 2006;7(1):61\u201370.","journal-title":"Respir Res"},{"issue":"9160","key":"808_CR19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)10261-1","volume":"353","author":"IJ Jacobs","year":"1999","unstructured":"Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet. 1999;353(9160):1207\u201310.","journal-title":"Lancet"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0808-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0808-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0808-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T14:30:08Z","timestamp":1564929008000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0808-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0808-0","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]},"article-number":"808"}}